Overview of pathological diagnosis

Pathological diagnosis is a medical method to determine the nature, type and severity of a disease through microscopic observation and laboratory analysis of tissue, cells or body fluid samples. It is the "gold standard" for clinical diagnosis and plays a central role in tumors, infectious diseases and autoimmune diseases. The main contents includeHistopathology(such as biopsy),Cytopathology(such as cervical smear) andmolecular pathology(such as genetic testing). The results of pathological diagnosis directly affect the selection of treatment options and prognosis assessment, and are an important part of precision medicine.

Core technologies for pathological diagnosis

Pathological diagnosis relies on a variety of techniques:Conventional HE stainingIt is the most basic method, observing tissue morphology through a microscope;ImmunohistochemistryUse antibodies to label specific proteins to assist in identifying tumor types;Molecular testing(such as PCR, gene sequencing) can identify mutated genes and guide targeted treatments. For example, HER2 detection in breast cancer requires a combination of immunohistochemistry and FISH techniques. The combined application of these technologies improves diagnostic accuracy and personalization.

Clinical application of pathological diagnosis

In the field of tumors, pathological diagnosis can clarify benign and malignant, grade and stage and molecular characteristics. For example, PD-L1 detection of lung cancer guides immunotherapy. In non-neoplastic diseases, renal biopsy can diagnose the type of nephritis, and bone marrow examination can distinguish leukemia subtypes. Pathology reports usually containMorphological description,immunophenotypeandmolecular resultsThe three parts provide key basis for multidisciplinary consultation (MDT).

Challenges and Developments in Pathological Diagnosis

Despite advanced technology, pathological diagnosis still facesSample quality,interpreting subjectivityWaiting for challenges. Artificial intelligence-assisted diagnosis (such as digital pathology systems) is on the rise, and Roche's VENTANA DP200 system can improve efficiency. In addition, non-invasive technologies such as liquid biopsy provide new options for patients with advanced disease. In the future, multi-omics integration (genome + proteome) will promote the development of pathological diagnosis in a more accurate direction.

Summary and Outlook

Pathological diagnosis is a bridge connecting basic research and clinical practice, and its technological advancements continue to rewrite disease management strategies. With the popularization of automated equipment and AI, the diagnostic cycle has been shortened, but the experience of pathologists is still irreplaceable. Standardized operating procedures and interdisciplinary cooperation are the focus of the future to ultimately achieve the goal of "individualized pathology."

Quote sources:
1. "Pathology" (9th edition), People's Medical Publishing House, edited by Li Yulin.
2. World Health Organization (WHO) tumor classification criteria (2020 edition).
3. Roche official website: VENTANA digital pathology system technology white paper.
4. College of American Pathologists (CAP) Clinical Guidelines.